Chase C. Leavitt - General Counsel/Secretary at Oncternal Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel/Secretary
Issuer Symbol
ONCT
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Chase C. Leavitt since 10 Mar 2025

Holdings reported by Chase C. Leavitt for Oncternal Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 84,758 $42,048 $0.4961 03 Jan 2024 Direct
Stock Option 14,200 14 Feb 2024 Direct Common Stock

Transactions reported by Chase C. Leavitt for Oncternal Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.